Click here to download the August 2020 edition.
A Global Approach to Oncology: Q&A with Justin Holko
The Regeneron SVP details the company’s approach to reaching oncology patients across the planet.
Predicting and Planning for Tariff Impacts: Q&A with Bill Coyle
The chaotic tariff situation is forcing pharma companies to prepare for multiple outcomes.
The Risks and Opportunities of Tariffs: Q&A with Marcel Botha
While supply chain interruptions are a strong possibility, the tariffs also provide the industry with a chance to improve certain conditions.
Bringing Biotech Innovation Across Borders
Four tips for midsized companies when entering new global markets.
ABPI Restores Novo Nordisk’s Membership
The pharmaceutical company had previously been subjected to a 2-year suspension.
The Challenges of Market Access in Europe that Pharma Companies Face: Q&A with Mike Ryan
Pharma companies face unique challenges with market access in this region.
